Should I Stop Hydralazine Before Surgery?

When It Makes Sense

• Good fit: You have well‑controlled blood pressure on a stable dose of hydralazine, the surgery is elective, and your cardiologist advises a short washout period to minimize intra‑operative hypotension.
• Good fit: The procedure involves significant fluid shifts or blood loss (e.g., major abdominal or orthopedic surgery) where rapid changes in blood pressure could complicate anesthesia management.

When You Should Avoid It

• Warning sign: You have severe, untreated hypertension or a history of hypertensive emergencies; stopping hydralazine could trigger dangerous spikes in pressure.
• Warning sign: You are on hydralazine as part of a combination regimen for heart failure with reduced ejection fraction; abrupt cessation may worsen cardiac output and precipitate decompensation.

Pros and Cons

Pros

• Reducing the risk of intra‑operative hypotension, which can improve surgical field visibility and decrease the need for vasopressor support.
• Allowing anesthesiologists to manage blood pressure with agents they are more familiar with, potentially leading to smoother hemodynamic control.

Cons

• Potential for rebound hypertension, which can increase bleeding risk, stress the cardiovascular system, and complicate postoperative recovery.
• Disruption of a long‑standing antihypertensive regimen may cause patient anxiety and require close monitoring, adding logistical complexity.

Decision Checklist

• Has your cardiologist or primary care physician evaluated the stability of your blood pressure and heart condition for a temporary drug holiday?
• Is the surgery elective or urgent, and does the surgical team have a clear plan for managing blood pressure without hydralazine?
• Do you have a monitoring plan (e.g., home BP checks, pre‑op clinic visit) to detect rebound hypertension before the operation?

Alternatives to Consider

If stopping hydralazine feels risky, discuss alternative strategies with your care team. Options may include switching to a short‑acting vasodilator that can be titrated intra‑operatively, adding a beta‑blocker or calcium‑channel blocker for added control, or simply continuing hydralazine at the same dose while ensuring the anesthesia team is prepared to counteract any hypotensive effects.

Final Recommendation

In most elective surgeries where blood pressure is already stable, a brief interruption of hydralazine—under the guidance of your cardiologist and surgeon—can be reasonable. However, if you have uncontrolled hypertension, heart‑failure dependence on the drug, or are facing urgent surgery, continuing hydralazine and planning for intra‑operative management is typically safer. Always involve both your prescribing physician and the operative team before making any changes, and follow any monitoring plan they provide.